Our results revealed that the promoter methylation levels of FDX1 and DLAT were substantially reduced in ccRCC compared to normal tissues, suggesting that the changes in FDX1 and DLAT expression are due to this epigenetic modification. The gene discussed is FDX1; the disease is nonpapillary renal cell carcinoma.